Search for: "Novartis Corporation "
Results 161 - 180
of 312
Sort by Relevance
|
Sort by Date
27 Aug 2011, 7:55 pm
This is "the sport of kings," that only large corporations can play. [read post]
23 Aug 2011, 2:46 pm
Genetics points out that the outcome of this § 291 action “will have real-world consequences,” because Genetics’ corporate parent, Wyeth, has been sued for allegedly infringing the Novartis patents in a related case in the United States District Court for the Eastern District of Texas. [read post]
23 Aug 2011, 2:46 pm
Genetics points out that the outcome of this § 291 action “will have real-world consequences,” because Genetics’ corporate parent, Wyeth, has been sued for allegedly infringing the Novartis patents in a related case in the United States District Court for the Eastern District of Texas. [read post]
11 Aug 2011, 4:43 am
NOVARTIS PHARMACEUTICALS CORPORATION, App. [read post]
27 Jul 2011, 1:01 am
Highlights this week included: Corporate self-interest and strategic choices: Gilead licenses to Medicines Patent Pool (IP Watch) (KEI) Glybera (Alipogene tiparvovec) – EU: EMA continues to defer approval of first gene therapy application in Europe (Patent Docs) Cenestin (Synthetic conjugated estrogens) – US: CAFC: Prosecution history estoppel bars Duramed’s allegations of infringement under doctrine of equivalents: Duramed Pharmaceuticals, Inc. v. [read post]
24 Jul 2011, 1:21 pm
See In re Novartis, 611 F.3d at 154. [read post]
11 Jul 2011, 4:47 pm
Kudos to The RPM Report team, which took note of some statements made during a recent meeting of FDA’s Arthritis Drugs Advisory Committee to discuss Novartis Pharmaceuticals Corporation’s (“Novartis’”) supplemental Biologics License Application (“sBLA”) for ILARIS (canakinumab) for the treatment of gouty arthritis attacks in certain patients. [read post]
6 Jul 2011, 2:21 am
(Patent Baristas) US: FDA’s Chief Counsel, Ralph Tyler, set to leave FDA (FDA Law Blog) US: Docs at BIO: Steve Burrill’s state of the biotechnology industry report 2011 (Patent Docs) US: Counterfeiting: White House IP Czar Victoria Espinel on working with corporations (BIOtechNOW) US: Banning gene patents will promote innovation? [read post]
30 May 2011, 7:34 am
The Court also shut down plaintiff’s efforts to get in irrelevant and prejudicial “corporate conduct” evidence from other experts and through corporate documents. [read post]
19 May 2011, 1:15 pm
Novartis Pharmaceuticals Corp., ___ F. [read post]
18 May 2011, 11:57 am
Novartis; the future of class arbitration in light of AT&T Mobility v. [read post]
18 Apr 2011, 5:51 pm
Prior to joining HP&M, Linda served in several pharmaceutical industry positions, including as Senior Director, Global Regulatory Policy and Intelligence, Janssen Pharmaceutical Companies of Johnson & Johnson, Executive Director, FDA Liaison, Drug Regulatory Affairs, Novartis Pharmaceuticals Corporation, and Director, Global Regulatory Affairs, Legislative Policy and Regulatory Liaison, Pharmacia Corporation. [read post]
26 Mar 2011, 10:17 am
Similar lawsuits have been filed recently against other major companies: Publicis Group S.A., the U.S. business and French advertising company for Toshiba Corp.; Goldman Sachs Group Inc.; and the U.S. unit of Novartis AG. [read post]
23 Mar 2011, 1:30 pm
Additional support for this research was provided by the NIH National Center for Research Resources and Novartis Pharmaceuticals Corporation. [read post]
16 Mar 2011, 9:25 am
Sutherland v. [read post]
15 Mar 2011, 1:31 pm
Score one for their side.Opinions about Novartis’s corporate conduct. [read post]
2 Mar 2011, 7:44 am
Novartis [link to blog post], the brief cites to the class action consent decrees in Hayes v. [read post]
2 Mar 2011, 7:44 am
Novartis [link to blog post], the brief cites to the class action consent decrees in Hayes v. [read post]
1 Mar 2011, 4:09 am
Lopes, Simona M. and Schering Corporation v. [read post]
17 Feb 2011, 1:59 pm
SmithKline Beecham Corporation (“Glaxo”) hired plaintiffs in 2003 to meet with physicians and encourage them to prescribe Glaxo pharmaceuticals. [read post]
